Skip to content
akaturk Academic measurement
2021 JCR Q3 · 0,6 OA 49 matched articles ESCI

Journal detail

Clinical Case Reports (discontinued)

Publisher
John Wiley and Sons Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 20500904
Scopus SJR
Scopus - SJR Q
WoS Q3 JCR Q
WoS 0,6 JIF
Scopus 22 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR
  • Quartile -
  • H-Index 22
  • Cites/doc 0,62
  • Docs (3y) 1.883
  • Cites (3y) 1.225

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 0,6
  • 5Y JIF 0,6
  • JCI 0,19

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Medicine (miscellaneous)

Areas

  • Medicine

WoS categories

  • Medicine, General & Internal

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 0,6 0,6 0,19 Q3
2024 Q3 0,6 0,6 0,19 Q3
2023 Q3 0,6 0,6 0,19 Q3
2022 0,7 0,7 0,18 Q3
2021 0,16 Q3 22
2020 Q4 0,21 0,2 Q3 22
2019 Q4 0,171 22
2017 22
2016 22
2015 22
2014 22
2013 22

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 MEDICINE, GENERAL & INTERNAL ESCI Q3 Q3 227/336
2024 MEDICINE, GENERAL & INTERNAL ESCI Q3 Q3 214/332
2023 MEDICINE, GENERAL & INTERNAL ESCI Q3 Q3 221/329
2022 MEDICINE, GENERAL & INTERNAL ESCI Q3
2021 MEDICINE, GENERAL & INTERNAL ESCI Q3
2020 MEDICINE, GENERAL & INTERNAL ESCI Q3